This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Analyst Blog: Archive
What to Expect From These 3 Energy Stocks This Earnings Season?
by Seema Agarwal
Energy stocks like PBA, CTRA and LNG face a mixed Q4 as oil prices tumble and natural gas rallies, setting the stage for sharp earnings contrasts.
LNGNegative Net Change PBAPositive Net Change CTRANegative Net Change
energy oil-energy
What's in Store for These 3 Restaurant Stocks in Q4 Earnings?
by Mrithunjoy Kaushik
PZZA, SG and SHAK gear up for Q4 results as value deals, digital push and cost pressures shape restaurant sector performance.
PZZANegative Net Change SHAKNegative Net Change SGNegative Net Change
earnings restaurants retail
What's in Store for These 5 Medical Companies This Earnings Season?
by Ahan Chakraborty
IRWD, RXRX, NVAX, VTRS and NTLA gear up for earnings as the Medical sector posts solid sales growth despite a slight profit dip so far.
IRWDPositive Net Change NVAXPositive Net Change NTLANegative Net Change VTRSNegative Net Change RXRXNegative Net Change
biotechnology biotechs earnings medical pharmaceuticals
Beverage Stocks Earnings Roster Next Week: KDP, MNST, FMX, SAM
by Rashmi Jaiswal
Beverage stocks enter fourth-quarter 2025 earnings under pressure from weak demand and costs, even as pricing, premiumization and health-focused launches offer support.
FMXNegative Net Change MNSTPositive Net Change SAMPositive Net Change KDPNegative Net Change
consumer-staples earnings
Are These 3 Energy Stocks Set to Beat Q4 Earnings Estimates?
by Seema Agarwal
Oil slumps while natural gas surges in Q4. Can FTI, RIG and TRGP defy pricing pressures and beat earnings estimates?
RIGNegative Net Change FTIPositive Net Change TRGPNegative Net Change
energy oil-energy
What to Expect From These Drug/Biotech Players This Earnings Season?
by Ekta Bagri
Let's take a closer look at what awaits Bausch Health, Amicus Therapeutics, BioMarin Pharmaceutical, Insmed and Madrigal Pharmaceuticals as they prepare to report quarterly results this week.
BMRNPositive Net Change FOLDNegative Net Change INSMPositive Net Change MDGLNegative Net Change BHCPositive Net Change
biotechnology biotechs earnings medical pharmaceuticals
What's in Store For These 5 Construction Stocks This Earnings Season?
by Sraddha Singha
Can public infrastructure strength offset the housing softness for these five construction stocks this earnings season?
FLRNegative Net Change VMCNegative Net Change LPXPositive Net Change TOLNegative Net Change GLDDNegative Net Change
construction earnings home-builder
Will These 3 Auto Stocks Surpass Q4 Earnings Forecasts?
by Rimmi Singhi
AAP, MGA and DCH are set to report Q4 results tomorrow. Read on to know how these companies are positioned ahead of their releases.
MGANegative Net Change AAPNegative Net Change DCHPositive Net Change
auto-tires-trucks
Medical Device Stocks to Report Earnings on Feb. 12: BAX, WST & DXCM
by Indrajit Bandyopadhyay
BAX, WST & DXCM gear up for Q4 earnings amid macro pressure, steady revenue growth and AI-driven demand.
BAXNegative Net Change DXCMNegative Net Change WSTNegative Net Change
medical medical-devices
Are These 4 Energy Stocks Set to Beat Q4 Earnings Estimates?
by Turjya Saha
Here is a look at what to expect from energy stocks, like AR, NBR, TTE and PDS, ahead of their quarterly earnings reports, set to be released tomorrow.
NBRNegative Net Change PDSPositive Net Change ARNegative Net Change TTENegative Net Change
energy oil-energy